GeneDx Holdings (WGS) Depreciation & Amortization (CF) (2020 - 2026)

GeneDx Holdings has disclosed Depreciation & Amortization (CF) across 7 years of filings, most recently posting $6.8 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 19.92% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $26.4 million (up 17.75% YoY), while the FY2025 annual figure was $25.2 million, up 14.9% from the prior year.
• Depreciation & Amortization (CF) retreated to $6.8 million in Q1 2026, from $6.9 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for WGS reached as high as $34.0 million in Q4 2022 and fell as low as $5.2 million in Q2 2024.
• The 5-year median for Depreciation & Amortization (CF) is $6.5 million (2025), against an average of $8.6 million.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) jumped 487.4% — and 2023, when it sank 82.1%.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $34.0 million in 2022, then slumped by 82.1% to $6.1 million in 2023, then fell by 8.8% to $5.6 million in 2024, then advanced by 23.8% to $6.9 million in 2025, then declined by 1.05% to $6.8 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $6.8 million, $6.9 million, and $6.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.